ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Administrative Data"

  • Abstract Number: 0723 • ACR Convergence 2024

    Sociodemographic Factors Associated with Clinic Non-attendance and Unscheduled Emergency Care Episodes in ANCA-associated Vasculitis

    Warren RG James1, Corri Black1, Neil Basu2, Mark A Little3 and Rosemary Hollick1, 1University of Aberdeen, Aberdeen, United Kingdom, 2University of Glasgow, Glasgow, Scotland, United Kingdom, 3Trinity College Dublin, Dublin, Ireland

    Background/Purpose: Increasing evidence suggests that socioeconomic status drives differences in outcomes for people with rheumatic conditions. Individuals with complex, rare rheumatic conditions such as antineutrophil…
  • Abstract Number: 1868 • ACR Convergence 2024

    Opioid Prescription Rates in Patients with Radiographic Axial Spondyloarthritis in the US Between 2008-2021: A Joinpoint Regression Analysis

    Berk Degirmenci1, Christine Peloquin2, Sara Lodi1, Pedro M Machado3, S. Reza Jafarzadeh2, Tuhina Neogi2, Lianne S Gensler4, Maureen Dubreuil5 and Jean Liew2, 1Boston University, Boston, MA, 2Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 3Department of Neuromuscular Diseases and Centre for Rheumatology, University College London, London, United Kingdom, 4Department of Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 5Section of Rheumatology, Boston University School of Medicine, Boston, MA

    Background/Purpose: Current axial spondyloarthritis (axSpA) guidelines do not provide recommendations for opioids in pain management. Opioid use is common in axSpA, despite widespread uptake of…
  • Abstract Number: 0806 • ACR Convergence 2024

    Rotavirus Vaccine in Offspring Exposed to Tumour Necrosis Factor Inhibitors During the Third Trimester Does Not Increase Diarrhea-Associated Healthcare Events

    Leah K. Flatman1, Sasha Bernatsky2, Isabelle Malhamé3, Yvan St-Pierre4, Olga Basso1, Anick Bérard5 and Evelyne Vinet3, 1McGill University, Montreal, QC, Canada, 2Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 3McGill University Health Centre, Montreal, QC, Canada, 4McGill University Health Center, Montreal, QC, Canada, 5Université de Montréal, Montreal, QC, Canada

    Background/Purpose: Until recently, best practice guidelines recommended withholding rotavirus vaccine in offspring exposed in utero to any TNFi until 6 months of age due to fears of…
  • Abstract Number: 1870 • ACR Convergence 2024

    Costs and Healthcare Resource Utilization Associated with Inpatient and Day Hospitalizations of Patients with Lupus and Psychiatric Manifestations in France

    Nicoleta Petrica1, Nathan Cohen1, Maria Pini1, Minjee Park2, Mathieu Rosé3 and Jean-Francois Ricci2, 1Alira Health, Paris, France, 2Alira Health, Basel, Switzerland, 3Alira Health, Barcelone, Spain

    Background/Purpose: Lupus, a rare chronic autoimmune disorder, severely impacts patients' quality of life, productivity, and survival, placing a heavy burden on the healthcare system. Up…
  • Abstract Number: 0980 • ACR Convergence 2024

    Ambient Air Pollution and Initiation of bDMARDs in Newly Diagnosed Rheumatoid Arthritis: A Nested Case-Control Study of NIH All of Us Cohort

    Jiayi Zheng1, Nevena Barjaktarovic2 and Liangjing lu3, 1Washington University School of Medicine, St. Louis, MO, 2The Wright Center for Community Health, South Abington Township, PA, 3Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China (People's Republic)

    Background/Purpose: Ambient air pollution is a mixture of solid particles and gaseous pollutants derived from fossil fuel combustion and vehicle exhaust. Previous research has linked…
  • Abstract Number: 1893 • ACR Convergence 2024

    Hydroxychloroquine Use in Early Pregnancy and Risk of Preterm Delivery in a Californian Cohort of Lupus Pregnancy

    Amadeia Rector1, Emily Liu2, Miranda Cantu3, Eliza Chakravarty4, Maurice Druzin5, Gary Shaw6, Michael Weisman7, Monique Hedderson2 and Julia Simard8, 1Stanford University, San Francisco, CA, 2Kaiser Permanente Division of Research, Oakland, CA, 3Patient partner, Portage, MI, 4Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Stanford University School of Medicine, Stanford, CA, 6Stanford University School of Medicine, Stanford, 7Stanford University, Los Angeles, CA, 8Stanford School of Medicine, Stanford, CA

    Background/Purpose: Preterm delivery (PTD) occurs 2-3 times more frequently in patients with systemic lupus erythematosus (SLE) compared to the general obstetric population. Hydroxychloroquine (HCQ), a…
  • Abstract Number: 1011 • ACR Convergence 2024

    Use of the Shingrix Vaccine Among Patients with Inflammatory Arthritis and Risk of Cardiovascular Events Following Herpes Zoster

    Jeffrey Curtis1, Danielle M Conrad2, Whitney S Krueger2, Andrew P Gara2 and Kevin Winthrop3, 1FASTER Medicine, Hoover, AL, 2AbbVie, North Chicago, IL, 3School of Medicine, Oregon Health and Science University, Portland, OR

    Background/Purpose: The risk of herpes zoster (HZ) is increased in patients with inflammatory arthritis (IA); although the Shingrix vaccine has been available since 2017, its…
  • Abstract Number: 1911 • ACR Convergence 2024

    Improving Healthcare Access in Underserved Brooklyn Communities: A Comprehensive Multispecialty Patient Navigator Program

    Meenakshi Kurup1, Grace Shadid2, Jasmine Pak2, Alejandra Moncayo3, Naureen Kabani4, Soodeh Kabir5, Sharon Glick5 and Ellen Ginzler6, 1SUNY Downstate Health Sciences University, Department of Medicine, Brooklyn, NY, 2SUNY Downstate College of Medicine, Brooklyn, NY, 3SUNY Downstate Health Sciences University, College of Medicine, Brooklyn, NY, 4SUNY Downstate Medical Center, Brooklyn, NY, 5SUNY Downstate Health Sciences University, Department of Dermatology, Brooklyn, NY, 6SUNY Downstate Health Sciences University, New York, NY

    Background/Purpose: Underserved communities in the USA face significant healthcare disparities, leading to poorer clinical outcomes and higher rates of chronic diseases. Socioeconomic barriers such as…
  • Abstract Number: 1051 • ACR Convergence 2024

    Healthcare Costs and Resource Utilization Associated with Long-term Medium-to-high Dose Oral Corticosteroid Use in Patients with Dermatomyositis or Polymyositis

    Daniel Labson1, Qian Cai2, Concetta Crivera3 and Federico Zazzetti4, 1Janssen Global Services, LLC, a Johnson & Johnson Company, Global Market Access RWE, Raritan, NJ, 2Janssen Global Services, LLC, a Johnson & Johnson Company, Global Market Access RWE, Titusville, NJ, 3Janssen Global Services, LLC, a Johnson & Johnson Company, Immunology Market Access, Horsham, PA, 4Johnson & Johnson Innovative Medicine, Horsham, PA, PA

    Background/Purpose: Dermatomyositis (DM) and polymyositis (PM) are rare autoimmune conditions primarily characterized by muscle weakness and inflammation. Real-world evidence on economic outcomes of patients with…
  • Abstract Number: 1954 • ACR Convergence 2024

    Examination of Rehabilitation Referrals from Rheumatology Practices for Adults with Rheumatoid Arthritis in the RISE Registry: A Feasibility and Descriptive Study

    Louise Thoma1, Jing Li2 and Gabriela Schmajuk3, 1University of North Carolina, Chapel Hill, NC, 2University of California, San Francisco, San Francisco, CA, 3UCSF / SFVA, San Francisco, CA

    Background/Purpose: Adults with rheumatoid arthritis (RA) commonly report functional limitations, pain, and fatigue that contribute to diminished quality of life and limit participation in valued…
  • Abstract Number: 1138 • ACR Convergence 2024

    Association Between Long-Term Exposure to Fine Particles and Its Components and the Onset of Systemic Autoimmune Rheumatic Diseases in Quebec

    Mareva geslin1, Julien Vachon2, Naizhuo Zhao3, Elhadji Anassour Laouan Sidi2, Sonia Jean4, audrey smargiassi2 and Sasha Bernatsky5, 1Universite de Montreal, Montreal, QC, Canada, 2Université de Montréal, Montreal, QC, Canada, 3McGill University, Montreal, QC, Canada, 4Institut national de santé publique du Québec, Montreal, QC, Canada, 5Research Institute of the McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: Exposure to fine particles (PM2.5) has been associated with numerous health effects including with autoimmune rheumatic diseases (SARDs). While PM2.5 are composed of various…
  • Abstract Number: 1984 • ACR Convergence 2024

    Use of ICD Codes for the Identification of Patients with Immune Checkpoint Inhibitor Induced Inflammatory Arthritis

    Tawnie Braaten1, Madeline O’Sullivan1, shardool Patel1, Sauer brian2, Jorge Rojas3, grant Cannon4 and miao Lai4, 1UNIVERSITY OF UTAH, Salt Lake City, UT, 2Salt Lake City VA/University of Utah, Salt Lake City, UT, 3Seattle VA, Mexico, Mexico, 4University of Utah and Salt Lake City VA, Salt Lake City, UT

    Background/Purpose: The identification of immune checkpoint inhibitor (ICI)-induced inflammatory arthritis (ICI-IA) using administrative data would provide a valuable advance in the investigation of ICI-IA.  The…
  • Abstract Number: 1214 • ACR Convergence 2024

    All-Cause Mortality in Patients with Chronic Musculoskeletal Pain Using Pregabalin or Duloxetine: A Retrospective Cohort Study in US Veterans

    Sachalee Campbell1, Laura L. Daniel2, Alyson L. Dickson3, Otis Wilson3, C. Michael Stein3, Puran Nepal4, Adriana M. Hung5 and Cecilia P. Chung2, 1University of Miami/ Jackson Health System, Miami, FL, 2University of Miami, Miami, FL, 3Vanderbilt University Medical Center, Nashville, TN, 4Vanderbilt University Medical Center, Vanderbilt, TN, 5Veterans Administration Tennessee Valley Healthcare System, Nashville, TN

    Background/Purpose: Musculoskeletal pain affects more than 10% of the general population. Recent trends in managing chronic musculoskeletal pain have favored non-opioid analgesics, for example, pregabalin,…
  • Abstract Number: 2001 • ACR Convergence 2024

    Complications and Treatment Use Associated with Long-term Oral Corticosteroid Therapy Among Patients with Dermatomyositis or Polymyositis

    Rohit Aggarwal1, Qian Cai2, Daniel Labson3, Concetta Crivera4 and Federico Zazzetti5, 1Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA, Pittsburgh, PA, 2Janssen Global Services, LLC, a Johnson & Johnson Company, Global Market Access RWE, Titusville, NJ, 3Janssen Global Services, LLC, a Johnson & Johnson Company, Global Market Access RWE, Raritan, NJ, 4Janssen Global Services, LLC, a Johnson & Johnson Company, Immunology Market Access, Horsham, PA, 5Johnson & Johnson Innovative Medicine, Horsham, PA, PA

    Background/Purpose: Idiopathic Inflammatory Myopathies (IIM) are a group of rare systemic autoimmune conditions mainly characterized by muscle weakness, rash and involvement of various organs. Dermatomyositis…
  • Abstract Number: 1215 • ACR Convergence 2024

    Mortality in US Veterans with Musculoskeletal Conditions Using Cyclobenzaprine or Baclofen

    Maria Intriago1, Puran Nepal2, Laura L. Daniel1, Alyson L. Dickson3, Otis Wilson3, C. Michael Stein3, Adriana M. Hung4 and Cecilia P. Chung1, 1University of Miami, Miami, FL, 2Vanderbilt University Medical Center, Vanderbilt, TN, 3Vanderbilt University Medical Center, Nashville, TN, 4Veterans Administration Tennessee Valley Healthcare System, Nashville, TN

    Background/Purpose: Cyclobenzaprine is a commonly-used centrally-acting muscle relaxant; it has been approved for short-term treatment of muscle spasms associated with acute musculoskeletal pain despite limited…
  • 1
  • 2
  • 3
  • …
  • 13
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology